(Q37769917)

22 August 2017

1 reference

title

In vitro evolution and analysis of HIV-1 LTR-specific recombinases (English)

1 reference

22 August 2017

0 references

1

Frank Buchholz

1 reference

22 August 2017

Joachim Hauber

2

1 reference

22 August 2017

publication date

26 June 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

53

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

102-109

1 reference

HIV-1 proviral DNA excision using an evolved recombinase

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Road to precision: recombinase-based targeting technologies for genome engineering.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

DNA recombination with a heterospecific Cre homolog identified from comparison of the pac-c1 regions of P1-related phages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Dre recombinase, like Cre, is a highly efficient site-specific recombinase in E. coli, mammalian cells and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

A structural view of cre-loxp site-specific recombination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Engineering DNA processing enzymes for the postgenomic era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Alteration of Cre recombinase site specificity by substrate-linked protein evolution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Evolution of variants of yeast site-specific recombinase Flp that utilize native genomic sequences as recombination target sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Directed evolution of the site specificity of Cre recombinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Why high-error-rate random mutagenesis libraries are enriched in functional and improved proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Genetic therapies against HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Virus-host interactions: role of HIV proteins Vif, Tat, and Rev.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Gene therapy progress and prospects: novel gene therapy approaches for AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Gene transfer into hematopoietic stem cells using lentiviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

HIV/AIDS: in search of an animal model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Experimental models to study development and function of the human immune system in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Human-Hemato-Lymphoid-System Mice: Opportunities and Challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Development of a human adaptive immune system in cord blood cell-transplanted mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Human adaptive immune system Rag2-/-gamma(c)-/- mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Experimental model for the study of the human immune system: production and monitoring of "human immune system" Rag2-/-gamma c-/- mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Newer antiretroviral agents and how to use them

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

The challenge of finding a cure for HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Site-specific recombination in human embryonic stem cells induced by cell-permeant Cre recombinase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

AIDS/HIV. A reversal of fortune in HIV-1 integration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Latency: the hidden HIV-1 challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

HAART-persistent HIV-1 latent reservoirs: their origin, mechanisms of stability and potential strategies for eradication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

Gene therapy. Intracellular immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

A third-generation lentivirus vector with a conditional packaging system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.06.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMETH.2010.06.014

1 reference

22 August 2017

1 reference